Literature DB >> 26805516

Do critical care units play a role in the management of gynaecological oncology patients? The contribution of gynaecologic oncologist in running critical care units.

Miona Davidovic-Grigoraki1, Nikolaos Thomakos1, Dimitrios Haidopoulos1, Giorgos Vlahos1, Alexandros Rodolakis1.   

Abstract

Routine post-operative care in high dependency unit (HDU), surgical intensive care unit (SICU) and intensive care unit (ICU) after high-risk gynaecological oncology surgical procedures may allow for greater recognition and correct management of post-operative complications, thereby reducing long-term morbidity and mortality. On the other hand, unnecessary admissions to these units lead to increased morbidity - nosocomial infections, increased length of hospital stay and higher hospital costs. Gynaecological oncology surgeons continue to look after their patient in the HDU/SICU and have the final role in decision-making on day-to-day basis, making it important to be well versed in critical care management and ensure the best care for their patients. Post-operative monitoring and the presence of comorbid illnesses are the most common reasons for admission to the HDU/SICU. Elderly and malnutritioned patients, as well as, bowel resection, blood loss or greater fluid resuscitation during the surgery have prolonged HDU/SICU stay. Patients with ovarian cancer have a worse survival outcome than the patients with other types of gynaecological cancer. Dependency care is a part of surgical management and it should be incorporated formally into gynaecologic oncology training programme.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  admission; gynaecological oncology surgery; high dependency unit; intensive care unit; outcome

Mesh:

Year:  2016        PMID: 26805516     DOI: 10.1111/ecc.12438

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  5 in total

Review 1.  Postoperative Admission in Critical Care Units Following Gynecologic Oncology Surgery: Outcomes Based on a Systematic Review and Authors' Recommendations.

Authors:  Nikolaos Thomakos; Anastasia Prodromidou; Dimitrios Haidopoulos; Nikolaos Machairas; Alexandros Rodolakis
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

2.  Machine Learning-Based Risk Prediction of Critical Care Unit Admission for Advanced Stage High Grade Serous Ovarian Cancer Patients Undergoing Cytoreductive Surgery: The Leeds-Natal Score.

Authors:  Alexandros Laios; Raissa Vanessa De Oliveira Silva; Daniel Lucas Dantas De Freitas; Yong Sheng Tan; Gwendolyn Saalmink; Albina Zubayraeva; Racheal Johnson; Angelika Kaufmann; Mohammed Otify; Richard Hutson; Amudha Thangavelu; Tim Broadhead; David Nugent; Georgios Theophilou; Kassio Michell Gomes de Lima; Diederick De Jong
Journal:  J Clin Med       Date:  2021-12-24       Impact factor: 4.241

Review 3.  Fertility preservation in women affected by gynaecological cancer: the importance of an integrated gynaecological and psychological approach.

Authors:  Valentina Lucia La Rosa; Simone Garzon; Giuseppe Gullo; Michele Fichera; Giovanni Sisti; Pasquale Gallo; Gaetano Riemma; Antonio Schiattarella
Journal:  Ecancermedicalscience       Date:  2020-05-06

4.  Management of ovarian cancer during the COVID-19 pandemic.

Authors:  Vincenzo Dario Mandato; Lorenzo Aguzzoli
Journal:  Int J Gynaecol Obstet       Date:  2020-04-29       Impact factor: 4.447

5.  Performing gynecologic cancer surgery during the COVID-19 pandemic in Turkey: A multicenter retrospective observational study.

Authors:  Polat Dursun; Haluk Dervisoglu; Mine Daggez; Taner Turan; Fatih Kiliç; Özlem M Tekin; Işin Üreyen; Tayfun Toptaş; Gökhan Demirayak; Ayşe B Önder; Çetin Çelik; Denizhan Bayramoğlu; Ahmet B Guzel; Dagistan T Arioz; Filiz Bilir; Isa A Ozdemir; Tolga Tasci; Alper Karalok; Ateş Karateke
Journal:  Int J Gynaecol Obstet       Date:  2020-08-11       Impact factor: 4.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.